echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > ARD: The use of tumor necrosis factor inhibitors during pregnancy is associated with increased birth weight in offspring in patients with rheumatoid arthritis

    ARD: The use of tumor necrosis factor inhibitors during pregnancy is associated with increased birth weight in offspring in patients with rheumatoid arthritis

    • Last Update: 2022-10-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Objective: Although the use of tumor necrosis factor inhibitors (TNFi) does not increase the risk of congenital malformations


    Methods: The patients were from a prospective study on pregnancy and RA (preconception counseling in active RA studies) and treated


    Results: Of the 188 patients included, 92 (48.


    Conclusions: This is the first study to show that the use of TNFi during pregnancy is associated with increased birth weight in offspring of well-controlled women with RA


     

    Source: Smeele HTW, Röder E, Mulders AGMGJ, Steegers EAP, Dolhain RJEM.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.